Get an inside look at the 18 ventures presenting at this year's Destination Startup® showcase, representing industries such as plant-based foods, DNA sequencing and more.
Big Blue Technologies
Big Blue Technologies makes magnesium metal using a novel process technology that consumes 60 percent less energy than the dominant incumbent process, translating to a reduction of cost of goods sold 50 percent lower than the monopolistic U.S. producer.
BioLoomics provides a B2B service to Pharma R&D companies that predicts clinically relevant effects of drugs using a high throughput platform drug screening technology.
Cetya Therapeutics is developing HDAC inhibitors which are analogs of largazole, a natural product Class I-restricted HDAC inhibitor. Cetya is focused in two key areas: (i) solid tumor indications in oncology and (ii) hemoglobinopathies such as sickle cell disease. We have drugs with excellent selectivity with early evidence of improved safety.
Earable aims to revolutionize cognitive healthcare with smart earphones that improve human's cognitive functions. Its pioneering work is at the intersection of breakthrough wearable sensing, signal processing and machine learning. The company is commercializing the world's first and most advanced in-ear health improvement platform for sleep, health, and other monitoring applications.
Emergy Foods has developed a proprietary process to produce food ingredients and finished goods made from fungal mycelium. The process is highly efficient and sustainable, using 2% of the land, water, and energy compared to traditional agriculture practices. The resulting ingredient is highly nutritious with > 55% complete protein.
Ezalife designs and develops medical devices that make life easier for infants, children and adults with complex medical needs. Its first product, the Button Huggie, is a precision-designed, low profile gastrostomy button securement device.
GenoFAB leverages the power of automation to increase the productivity of R&D in biotechnology.
Lab79 Technologies, Inc.
Lab79 Technologies is developing a method to sequence DNA by monitoring the changes in force as a piece of single-stranded DNA is pulled through an interface (for example, between water and air).
Microbial Pulse Diagnostics
Microbial Pulse Diagnostics will enable point-of-care data-driven antibiotic prescriptions by providing physicians with a list of proven effective drugs in under two hours. Its nanoscale sensing technology "takes the pulse" of the bacteria causing a urinary tract infection to quickly determine their phenotypic susceptibility or resistance to antibiotics.
New Iridium, LLC
New Iridium's platform of organic photo redox catalysts is the key enabler of next generation chemical manufacturing with photo redox catalysis that accelerates pharma drug development, reduces drug manufacturing costs and provides similar time and cost savings for chemical processing across many industries including plastics, agrochemical, energy and more.
OptiEnz Sensors has developed an instrumentation system, incorporating biosensors, for the continuous monitoring of organic chemical concentrations in water and aqueous solutions, with applications in the biopharma, biofuels, biotech, and beverage industries.
PhotonPharma is an immune oncology company that has developed a break- through technology to stimulates a patient’s own immune system to seek out and destroy their cancer cells.
SiVEC Biotechnologies is developing a breakthrough delivery platform for nucleic acid drugs and gene-editing tools using non-pathogenic, non-immunogenic bacteria for stable and specific delivery to mucosal tissues without host genomic integration.
Starfire Energy makes systems to produce carbon-free ammonia from air and water using clean electricity. Its systems leverage a patent-pending catalyst, novel removal method and specialized reactor. Ammonia can be combusted for energy, is an easy way to store and transport hydrogen and has more energy by volume than batteries.
Strivision is developing new forms of condition-oriented pulmonary diagnostic tools aimed at the early diagnosis of chronic respiratory conditions through infrared CO2 imaging and AI-driven image analysis. Its new form of visual data analytics provides the first viable method of identifying, tracking, and augmenting treatments for pulmonary conditions to improve patient quality of care and clinical outcomes.
TissueForm’s micro particle tissue technology targets scarring, wrinkles, and tissue loss due to aging or injury. Its novel material fills skin defects and provides a long-lasting treatment — saving patients time and improving their outcomes and self-confidence, while also increasing profitability of small private plastic surgery clinics.
VetMeasure is commercializing MeasureON!, a canine harness that monitors a patient's temperature, heart rate (with ECG capabilities), respiratory rate, and activity level - along with environmental temperature and humidity - in order to allow veterinarians to more efficiently monitor patients recovering from surgery or during a hospitalization stay.
VitriVax is developing a platform to make vaccines more accessible, more effective, and more affordable globally. Its proprietary technology, developed with support from the National Institute of Health (NIH), the State of Colorado, and the Bill & Melinda Gates Foundation, enables the creation of vaccines that don’t require refrigeration, and combine multiple doses into a single shot.